Mutations in PCYT1A cause spondylometaphyseal dysplasia with cone-rod dystrophy

Am J Hum Genet. 2014 Jan 2;94(1):113-9. doi: 10.1016/j.ajhg.2013.11.022.


Spondylometaphyseal dysplasia with cone-rod dystrophy is a rare autosomal-recessive disorder characterized by severe short stature, progressive lower-limb bowing, flattened vertebral bodies, metaphyseal involvement, and visual impairment caused by cone-rod dystrophy. Whole-exome sequencing of four individuals affected by this disorder from two Brazilian families identified two previously unreported homozygous mutations in PCYT1A. This gene encodes the alpha isoform of the phosphate cytidylyltransferase 1 choline enzyme, which is responsible for converting phosphocholine into cytidine diphosphate-choline, a key intermediate step in the phosphatidylcholine biosynthesis pathway. A different enzymatic defect in this pathway has been previously associated with a muscular dystrophy with mitochondrial structural abnormalities that does not have cartilage and/or bone or retinal involvement. Thus, the deregulation of the phosphatidylcholine pathway may play a role in multiple genetic diseases in humans, and further studies are necessary to uncover its precise pathogenic mechanisms and the entirety of its phenotypic spectrum.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Brazil
  • Child
  • Child, Preschool
  • Choline-Phosphate Cytidylyltransferase / genetics*
  • Choline-Phosphate Cytidylyltransferase / metabolism
  • Female
  • Genes, Recessive
  • Homozygote
  • Humans
  • Infant
  • Male
  • Ophthalmology / methods
  • Osteochondrodysplasias / genetics*
  • Pedigree
  • Retinitis Pigmentosa / genetics*


  • Choline-Phosphate Cytidylyltransferase
  • PCYT1A protein, human

Supplementary concepts

  • Spondylometaphyseal Dysplasia with Cone-Rod Dystrophy